TrialThe journal of physiological sciences : JPS2019

A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease.

Keisuke Miki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.